AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO)

Historical Holders from Q1 2016 to Q2 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CDMO
Shares outstanding
64,369,712
Price per share
$12.49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AltraVue Capital, LLC 5.9% $47,190,485 3,797,813 AltraVue Capital, LLC 31 Dec 2024

Institutional Holders of AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q2 0 $0 -$2,310 $12.49 0
2025 Q1 187 $2,310 -$824,565,589 $12.43 2
2024 Q4 67,862,644 $838,116,949 +$9,827,378 $12.35 195
2024 Q3 68,016,155 $773,946,793 +$65,042,281 $11.38 173
2024 Q2 65,075,067 $464,631,006 +$2,629,666 $7.14 168
2024 Q1 65,053,138 $435,854,542 +$50,206,742 $6.70 162
2023 Q4 303,474 $1,972,581 +$1,809,919 $6.50 3
2023 Q3 62,443,660 $589,445,039 -$28,362,358 $9.44 165
2023 Q2 62,731,973 $876,482,333 -$6,820,116 $13.97 163
2023 Q1 64,498,751 $1,209,777,008 -$5,266,844 $18.76 164
2022 Q4 63,536,131 $874,969,659 -$4,878,837 $13.77 159
2022 Q3 63,317,048 $1,210,069,236 +$31,215,335 $19.12 163
2022 Q2 60,768,338 $927,101,218 -$11,011,497 $15.26 175
2022 Q1 51,989,567 $1,059,435,238 +$53,661,838 $20.37 176
2021 Q4 61,287,083 $1,785,269,353 +$224,061,682 $29.18 182
2021 Q3 53,893,016 $1,161,553,828 +$19,307,283 $21.57 157
2021 Q2 52,834,754 $1,353,591,015 +$137,036,723 $25.65 166
2021 Q1 47,706,179 $870,106,962 +$164,156,022 $18.23 151
2020 Q4 39,269,264 $453,349,444 +$67,917,433 $11.54 140
2020 Q3 33,277,461 $253,598,469 +$32,082,014 $7.62 102
2020 Q2 29,018,611 $191,118,165 +$6,025,973 $6.56 92
2020 Q1 25,455,192 $130,015,968 -$6,415,672 $5.11 84
2019 Q4 28,552,745 $218,969,017 +$24,925,398 $7.67 103
2019 Q3 25,108,001 $132,941,040 +$7,377,697 $5.30 84
2019 Q2 23,835,800 $133,482,748 +$16,520,488 $5.60 84
2019 Q1 21,669,609 $92,076,450 -$4,952,392 $4.25 87
2018 Q4 22,365,486 $91,659,255 +$1,026,659 $4.10 91
2018 Q3 16,660,549 $114,285,258 +$33,579,989 $6.86 91
2018 Q2 12,062,874 $47,292,522 +$7,685,509 $3.92 66
2018 Q1 10,527,559 $30,752,327 +$28,247,402 $2.92 55
2017 Q4 257,323 $993,000 +$957,990 $3.87 3
2016 Q1 4,000 $17,000 $0 $4.25 1